Clinical Trials Directory

Trials / Unknown

UnknownNCT03126422

Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Yangzhou University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The investigators aimed to investigate the effects of pretreatment with different doses of dexmedetomidine on the cough caused by fentanyl during anesthetic induction. Patients undergoing elective surgeries under general anesthesia will be randomly allocated to 4 groups (n = 60, each group). Dexmedetomidine 0, 0.03, 0.06, and 0.09 μg/kg/min will be pump-administered in 10 mins to groups I, II, III, and IV, respectively, followed by the induction of general anesthesia with intravenous fentanyl 4 μg/kg. The incidences and severity of cough that occurred within 2 min after the injection of fentanyl will be recorded, and the incidences of cardiovascular adverse events that occurred between the administration of the dexmedetomidine infusion and 2 min after tracheal intubation will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinePretreatment of different doses of dexmedetomidine

Timeline

Start date
2017-05-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2017-04-24
Last updated
2017-07-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03126422. Inclusion in this directory is not an endorsement.

Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough (NCT03126422) · Clinical Trials Directory